Drug and alcohol dependence
Journal
Overview
publication venue for
-
Buprenorphine treatment and clinical outcomes under the opioid use disorder cascade of care..
263.
2024
-
Transitions of care between jail-based medications for opioid use disorder and ongoing treatment in the community: A retrospective cohort study..
261.
2024
-
Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial..
261.
2024
-
Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration..
259.
2024
-
Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004-2019..
257.
2024
-
Evaluating equity in community-based naloxone access among racial/ethnic groups in Massachusetts..
241.
2022
-
State prescribing cap laws' association with opioid analgesic prescribing and opioid overdose..
240.
2022
-
Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020..
232.
2022
-
Cost of Hepatitis C care facilitation for HIV/Hepatitis C Co-infected people who use drugs..
232.
2022
-
Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients..
232.
2022
-
Psychosocial and health problems associated with alcohol use disorder and cannabis use disorder in U.S. adults..
229.
2021
-
The association between prescription opioid dispensing and opioid-related morbidity and mortality in Ontario, Canada: an ecological study of public health units..
227.
2021
-
Estimating the community prevalence, child traits, and maternal risk factors of fetal alcohol spectrum disorders (FASD) from a random sample of school children..
227.
2021
-
Substance use and suicide outcomes among self-injured trauma patients..
226.
2021
-
Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort..
225.
2021
-
The role of stigma in U.S. primary care physicians' treatment of opioid use disorder..
221.
2021
-
Medical provider stigma experienced by people who use drugs (MPS-PWUD): Development and validation of a scale among people who currently inject drugs in New York City..
221.
2021
-
The cost of opioid use disorder and the value of aversion..
217.
2020
-
Impact of state-level cannabis legalization on poly use of alcohol and cannabis in the United States, 2004-2017..
218.
2020
-
Health economic design for cost, cost-effectiveness and simulation analyses in the HEALing Communities Study..
217.
2020
-
Comparing perspectives on medication treatment for opioid use disorder between national samples of primary care trainee physicians and attending physicians..
216.
2020
-
Health-related quality of life and opioid use disorder pharmacotherapy: A secondary analysis of a clinical trial..
215.
2020
-
Cannabis use among US adults with anxiety from 2008 to 2017: The role of state-level cannabis legalization..
214.
2020
-
Implementation and enforcement of state opioid prescribing laws..
213.
2020
-
Cannabis use during pregnancy in the United States: The role of depression..
210.
2020
-
Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort..
200.
2019
-
Recreational marijuana legalization and prescription opioids received by Medicaid enrollees..
194.
2018
-
Postmortem blood alcohol content among late-middle aged and older suicide decedents: Associations with suicide precipitating/risk factors, means, and other drug toxicology..
187.
2018
-
Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs..
185.
2018
-
Substance use and STI acquisition: Secondary analysis from the AWARE study..
169.
2016
-
Primary care physicians' perspectives on the prescription opioid epidemic..
165.
2016
-
Cost-effectiveness of an internet-delivered treatment for substance abuse: Data from a multisite randomized controlled trial..
161.
2016
-
Mortality among heroin users and users of other internationally regulated drugs: A 27-year follow-up of users in the Epidemiologic Catchment Area Program household samples..
156.
2015
-
An economic evaluation of a contingency-management intervention for stimulant use among community mental health patients with serious mental illness..
153.
2015
-
Antiretroviral therapy for prevention of HIV transmission: potential role for people who inject drugs in Central Asia..
132 Suppl 1.
2013
-
Prescription opioid mortality trends in New York City, 1990-2006: examining the emergence of an epidemic..
132.
2013
-
The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial..
128.
2012
-
Policing and risk of overdose mortality in urban neighborhoods..
113.
2010
-
The relationship between recreational gambling and substance abuse/dependence: data from a nationally representative sample..
100.
2008
-
Illicit drug use in young adults and subsequent decline in general health: the Coronary Artery Risk Development in Young Adults (CARDIA) Study..
88.
2006
-
Income distribution and risk of fatal drug overdose in New York City neighborhoods..
70.
2003
-
The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications..
69.
2003
-
Acute subjective effects of dynorphin A(1-13) infusion in normal healthy subjects..
54.
1999
-
Serum prolactin correlates with depressed mood during alcohol withdrawal..
17.
1986
-
Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States.
2022
-
Mindfulness meditation improves emotion regulation and reduces drug abuse.
2016
-
Short term health-related quality of life improvement during opioid agonist treatment.
2015
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)